Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

IVD Reps Propose Alternative 510(k) Route For In Vitro Analytical Tests

This article was originally published in The Gray Sheet

Executive Summary

An IVD industry proposal to foster a new 510(k) mechanism for innovative analyte test kits would offer a timely alternative to "homebrew" diagnostic tests

You may also be interested in...



Manufacturers’ Group Is Not Satisfied With FDA In-Vitro Diagnostics Office

Diagnostic manufacturers have not seen the improved review times they expected from the founding of the Office of In Vitro Diagnostic Device Evaluation & Safety (OIVD) in 2002, according to the chief counsel for the Association of Medical Diagnostic Manufacturers (AMDM)

Manufacturers’ Group Is Not Satisfied With FDA In-Vitro Diagnostics Office

Diagnostic manufacturers have not seen the improved review times they expected from the founding of the Office of In Vitro Diagnostic Device Evaluation & Safety (OIVD) in 2002, according to the chief counsel for the Association of Medical Diagnostic Manufacturers (AMDM)

AdvaMed Reworks ASR Language In Hopes Of Influencing New FDA Guidance

AdvaMed currently is gathering information, including legal opinions, on how current analyte specific reagent regulations could be altered

Related Content

UsernamePublicRestriction

Register

OM004514

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel